The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration

References

• Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486–495
   PubMed Web of Science ®Google Scholar
• Nangia V, Jonas JB, Kulkarni M, et al. The prevalence of age-related macular degeneration in rural central India: the Central India Eye and Medical Study. Retina 2011;31:1179–1185
   PubMedGoogle Scholar
• Ambati J, Ambati BK, Yoo SH, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257–293
   PubMed Web of Science ®Google Scholar
• Sarks SH, Arnold JJ, Killingsworth MC, et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 1999;83:358–368
   PubMed Web of Science ®Google Scholar
• Belkhiri A, Richards C, Whaley M, et al. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. Lab Invest 1997;77:533–539
   PubMed Web of Science ®Google Scholar
• Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006;69:625–635
   PubMed Web of Science ®Google Scholar
• Peten EP, Garcia-Perez A, Terada Y, et al. Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol 1992;263:951–957
   Google Scholar
• Atkison SJ, Petterson ML, Butler MJ, et al. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type I collagen in a cell model. FEBS Lett 2001;491:222–226
   PubMedGoogle Scholar
• Elliot SJ, Catanuto P, Espinosa-Heidman DG. Estrogen Receptor β protects against in vivo injury in RPE cells. Exp Eye Res 2010;90:10–16
   PubMed Web of Science ®Google Scholar
• Fiotti N, Pedio M, Battaglia PM, et al. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genet Med 2007;4:272–277
   Google Scholar
• Lesauskaitė V, Šinkūnaitė G, Benetis R, et al. MMP-3 gene polymorphism and dilatative pathology of ascending thoracic aorta. Medicina (Kaunas) 2008;44:386–391
   PubMedGoogle Scholar
• Samnegard A, Silveira P, Lundman S, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005;258:411–419
   PubMedGoogle Scholar
• Alge-Priglinger CS, Kreutzer T, Obholzer K, et al. Oxidative stress-mediated induction of MMP-1 and MMP-3 in human RPE cells. Invest Ophthalmol Vis Sci 2009;50:5495–5503
   PubMed Web of Science ®Google Scholar
• Steen B, Sejersen S, Berglin L, et al. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998;39:2194–2200
   PubMed Web of Science ®Google Scholar
• Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006;6:255–265
   PubMed Web of Science ®Google Scholar
• Grabauskas V, Miseviciene I, Klumbiene J, et al. Prevalence of dyslipidemias among Lithuanian rural population (CINDI program). Medicina (Kaunas) 2003;39:1215–1222
   PubMedGoogle Scholar
• Lesauskaite V, Macijauskiene J, Rader E. Challenges and opportunities of health care for the aging community in Lithuania. Gerontol 2006;52:40–44
   PubMed Web of Science ®Google Scholar
• The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2011;132:668–681
   Google Scholar
• Chong NH, Keonin J, Luthert PJ, et al. Decreased thickness and integrity of the macular elastic layer of Bruch’s membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol 2005;166:241–251
   PubMed Web of Science ®Google Scholar
• Spraul CW, Lang GE, Grossniklaus HE, et al. Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 1999;44:10–32
   PubMed Web of Science ®Google Scholar
• Lim CS, Shalhoub J, Gohel MS, et al. Matrix metalloproteinases in vascular disease – a potential therapeutic target? Curr Vasc Pharmacol 2010;8:75–85
   PubMed Web of Science ®Google Scholar
• Wang JJ, Foran S, Smith W, et al. Risk of age-related macular degeneration in eyes with macular drusen or hyper-pigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 2003;121:658–663
   PubMedGoogle Scholar
• Chau KY, Sivprasad S, Patel N, et al. Plasma levels of matrix metalloproteinases-2 and -9 in age-related macular degeneration. Eye (Lond) 2007;21:1511–1515
   PubMed Web of Science ®Google Scholar
• Lambert V, Munaut C, Jost M, et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol 2002;161:1247–1253
   PubMed Web of Science ®Google Scholar
• Zeng R, Wen F, Zhang X, et al. Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Mol Vis 2013;19:729–736
   PubMed Web of Science ®Google Scholar
• Jonas JB, Tao Y, Neumaier M, et al. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol (Copenh) 2012;90:381–388
   PubMed Web of Science ®Google Scholar
• Zeng J, Jiang D, Liu X, et al. Matrix metalloproteinases expression in choroidal neovascular membranes. Yan Ke Xue Bao 2004;20:191–193
   PubMedGoogle Scholar
• Hussain AA, Lee Y, Zhang JJ, et al. Disturbed matrix metalloproteinase activity of Bruch’s membrane in age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:4459–4466
   PubMed Web of Science ®Google Scholar
• Chaer RA, Billeh R, Massad MG. Genetics and gene manipulation therapy of premature coronary artery disease. Cardiology 2004;101:122–130
   PubMed Web of Science ®Google Scholar
• Berglin L, Sarman S, van der Ploeg I, et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 2003;44:403–408
   PubMed Web of Science ®Google Scholar
• Seitzman RL, Mahajan VB, Mangione C, et al. Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women. Am J Epidemiol 2008;167:1217–1225
   PubMed Web of Science ®Google Scholar
• Ortak H, Demir S, Ateş O, et al. The role of MMP2 (−1306C > T) and TIMP2 (−418 G > C) promoter variants in age-related macular degeneration. Ophthalmic Genet 2013; Mar 28 [Epub ahead of print]
   Google Scholar
• Wang JJ, Xu G, Wu X, et al. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 2011;97:1542–1546
   PubMed Web of Science ®Google Scholar
• Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493–2503
   PubMed Web of Science ®Google Scholar
• Wieczorek E, Reszka E, Gromadzinska J, et al. Genetic polymorphism of matrix metalloproteinases in breast cancer. Neoplasma 2012;59:237–247
   PubMedGoogle Scholar
• Itoh T, Matsuda H, Tanioka M, et al. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002;169:2643–2647
   PubMed Web of Science ®Google Scholar